Tarsus Pharmaceuticals Inc
TARS
$74.40+1.69%
End of day · as of Oct 13, 2026, 8:30 AM ET
Mkt cap
$2.66B
EV/Sales
5.65
P/E ratio
N/A
FY2025 Revenue
$451.36M
EPS (TTM)
$-1.07
Gross Margin (FY2025)
N/A
Profit Margin (FY2025)
-14.72%
Beta
N/A
Div yield
N/A
Sector
Healthcare
Tarsus Pharmaceuticals Inc (TARS) is a biotechnology company listed on NASDAQ.
Latest reported TARS revenue for 2025-12-31 was $451.4M. Net income was -$66.4M. Revenue was up 146.7% from 2024-12-31 to 2025-12-31. TARS currently screens at market cap $2.66B.
Use this TARS research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full TARS income, balance, and cash tables.
† Total Debt: Derived from long-term debt only (no total or short-term debt stored).
Tarsus Pharmaceuticals Inc (TARS) is a biotechnology company in the Healthcare sector.
Latest cached Tarsus Pharmaceuticals Inc (TARS) revenue for Dec 31, 2025 was $451.4M. Net income was -$66.4M. Statements: https://lician.com/financials/tars
Tarsus Pharmaceuticals Inc (TARS) market capitalization is $2.66B on the latest cached snapshot.
Tarsus Pharmaceuticals Inc (TARS) cached previous close $73.16; day range $73.20 – $74.40; volume 732,882. Session quote: https://lician.com/quote/tars
Tarsus Pharmaceuticals Inc (TARS) latest cached earnings event is "TARS earnings" on Aug 6, 2026. Earnings calendar: https://lician.com/earnings
The latest cached TARS filing is 8-K/A · Oct 13, 2026. Filings: https://lician.com/sec/tars